Summary of the updated stage 3 guideline for early detection of breast cancer in Germany 2008;Kurzfassung der aktualisierten stufe-3-leitlinie brustkrebs- früherkennung in Deutschland 2008

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 180, Issue 5, 2008, Pages 455-465

  Albert, Ute Susann ^a,b   Altland, H ^a   Duda, V ^a   Engel, J ^a   Geraedts, M ^a   Heywang Kobrunner S ^a   Holzel D ^a   Kalbheim, E ^a   Koller, M ^a   Konig K ^a   Kreienberg, R ^a   Kuhn T ^a   Lebeau, A ^a   Nass Griegoleit I ^a   Schlake, W ^a   Schmutzler, R ^a   Schreer, I ^a   Schulte, H ^a   Schulz Wendtland, R ^a   Wagner, U ^a   Kopp, I ^a   more..

^a Planungskommission und Arbeitsgruppenleiter der Konzertierten Aktion Brustkrebs Fruherkennung ^*

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; GERMANY; HUMAN; MAMMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ALGORITHM; ARTICLE; BIOPSY; BREAST; BREAST TUMOR; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; FEMALE; HEALTH CARE QUALITY; MASS SCREENING; PATHOLOGY; RADIOGRAPHY; TOTAL QUALITY MANAGEMENT;

ALGORITHMS; BIOPSY; BREAST; BREAST NEOPLASMS; EARLY DIAGNOSIS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; QUALITY INDICATORS, HEALTH CARE; TOTAL QUALITY MANAGEMENT; ULTRASONOGRAPHY, MAMMARY;

EID: 47149086985     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027320     Document Type: Review

References (57)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Annals of Oncology 18-12-2006 10.1.093/annonc/imd498
2. Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. und das Robert Koch-Institut. Krebs in Deutschland - Häufigkeiten und Trends, ed 5. überarbeitete, aktualisierte Auflage. Saarbrücken RoBo Print, Riegelsberg 2006
3. Brenner H, Stegmaier C, Ziegler H. Verbesserte Langzeitüberlebensraten von Krebspatienten. Die unterschätzten Fortschritte der Onkologie. Dtsch Ärztebl 2005; 102: 2628-2633
4. Albert US, Schulz KD, Kopp I. Leitlinien-Methodenreport: Aktualisierung der Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland 2007. ed konsultierte Fassung Version 1.1. Marburg: http//www.awmf-leitlinien.de 2007
5. Lorenz W, Ollenschläger G, Geraedts M, Gerlach F, Gangjour A, Helou A, Kirchner H, Koller M, Lauterbach W, Reinauer H, Sitter H, Thomeczek C. Das Leitlinien Manual: Entwicklung und Implementierung von Leitlinien in der Medizin. ZaeFQ 2001; 95: 1-84
6. Encke A, Kopp I, Selbmann H, Hoppe J, Köhler A, Ollenschläger G Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Ärztliches Zentrum für Qualität in der Medizin (ÄZQ) (Hrsg). Deutsches Instrument zur methodischen Bewertung von Leitlinien: DELBI. Dt Ärztebl 2006; 102: A1912-A1913
7. Kopp I, Encke A, Lorenz W. Leitlinien als Instrument der Qualitätssicherung in der Medizin. Bundesgesundheitsbl-Gesundheitsforsch- Gesundheitsschutz 2002; 45: 223-233
8. Nothacker M, Lelgemann M, Giersiepen K, Weinbrenner S. Evidenzbericht 2007 zur S-3-Leitlinie Brustkrebsfrüherkennung in Deutschland. Band 31. ed Version 1.00. Berlin Ärztliches Zentrum für Qualität in der Medizin (ÄZQ) http://www.aezq.de/publikationen0index/ schriftenreihe/view, http://www.awmf-leitlinien.de 2007
9. Schulz KD, Albert US und die Mitglieder der Arbeitsgruppe "Konzertierte Aktion: Brustkrebs-Früherkennung in Deutschland" . Stufe 3 Leitlinie Brustkrebs-Früherkennung in Deutschland, ed 1. München Zuckschwerdt Verlag 2003
10. Perry N, Breeders M, de Wolf C, Törnberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg European Communities Publication, 2006
11. World Health Organisation (WHO). National Cancer Control Programms: Policies and managerial Guidelines. 2nd ed. Geneva, Italy Health and Development Networks (HDN), 2002
12. Hoffmann W, Latza U, Terschüren C, Berger K, Bergmann M, Dahl A, Fendrich K, Gierer S, Holle R, Jahn I, Schümann M, Steindorf K. Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP) - Langversion. 2. Aufl. mit Änderungen nach Evaluation. Münster: Arbeitsgruppe Epidemiologischer Methoden der Deutschen Arbeitsgemeinschaft für Epidemiologie (DAE); Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (GMDS); Deutsche Gesellschaft für Sozialmedizin und Prävention (DGSMP); Deutsche Regionen der Internationalen Biometrischen Gesellschaft (DR-IBS); 1. Aufl.: Kurth BM, Hense HW, Hoffmann W, Ahrens W, Babitsch B, Becher H, Blettner M, Brasche S, Brenner H, Enderlein G, Greiser KH, Jahn I, Jöckel KH, Kirschner W, Kohlmann T, Liese A, Möhner M, Mueller U, Reintjes R, Stang A, Wyst M. http://www.medweb.uni- muenster.de/institute/epi/dae/vorstand.html, 2004
13. NBCC National Breast Cancer Center. Clinical practice guidelines for the management of early breast cancer. ed i Soruce. Australia NBCC National Breast Cancer Center (http://www.nbcc.org.au), 2001
14. Smith R, Sastow D, Sawyer K, Burke W, Costanza M, Evans W, Foster RJr., Hendrick E, Eyre H, Sener S. American Cancer Society guidelines for breast cancer screening. Update 2003. CA Cancer Journal of Clinicans, 2003; 53: 141-169 (http://www.caonline.amcancersoc.org/cgi/content/full/53/3/141)
15. Brett J, Bankhead C, Henderson B, Watson E, Austoker J. The psychological impact of mammographic screening. A systematic review. Psycho-Oncology 2005; 14: 917-938
16. Albert US, Schulz KD, Alt D, Beck V, Doherty J, Holsteg K, Kalbheim E, Müller J, Nass-Griegoleit I, Nill J, Nioduschewski G, Schulte H, von Wietersheim A, Kopp I. Eine Leitlinie für Leitlinien: die methodische Entwicklung und Anwendung der Leitlinie Fraueninformation. Zentralbl Gynakol 2003; 125: 484-493 (AWMF Reg. Nr.: 077-002; www.awmf-leitlinien.de)
17. NHS Centre for Reviews and Dissemination. Effective Health Care: Informing, communicating and sharing decision with people who have cancer. Plymouth Latimer Trend & Company Ltd 2000
18. NCCN National Comprehensive Cancer Network. Breast Cancer. USA: NCCN Clinical Practice Guidelines in Oncology ( www.nccn.org) 2006
19. NCCN National Comprehensive Cancer Network. Breast cancer screening and diagnosis guidelines. USA: NCCN Clinical Practice Guidelines in Oncology (http://www.nccn.org), 2007
20. Calman K, Hine D, Peto R, Boreham J, Clarke M, Purushotham A, Pain S, Miles D. NICE: Improving outcomes in breast cancer. London NICE, 2002
21. NICE NCCfPC. Familial breast cancer - The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. Update July 2006. NICE (www.nice.org.uk/CG041), 2006
22. SIGN Scottish Intecollegiate Guideline Network. Management of breast cancer in women. Edinburgh SIGN (www.sign.ac.uk), 2005
23. Smith R, Caleffi M, Albert US, Chen T, Duffy S, Franceschi D, Nyström L. Breast cancer in limited-resource countries: Early detection and access to care. The Breast J 2006; 12: S16-S26
24. NICE. NICE clinical guideline no 27: Referral guidelines for suspected cancer. NICE (www.nice.org.uk/CG027), 2005
25. NBCC. The investigation of a new breast symptom - a guide for GP. Australia: NBCC (http://www.nbcc.org.au), 2006
26. NBCC. Position Statement early detection of breast cancer. In: NBCC (ed). Canberra National Health and Medical Research Council (http://www.nbcc.org.au), 2004
27. NBCC National Breast Cancer Centre. Evidence relevant to guidelines for the investigation of breast symptoms. 2nd ed. Camperdown, Australia National Breast Cancer Centre (www.nbcc.org.au), 2006
28. NBCC. Clinical practice guidelines for the management and support of younger women with breast cancer. 1st ed. Camperdown, NSW National Health and Medical Research Council (NHMRC) (http://www.nbcc.org.au), 2004
29. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews 18-10-2006; Art.No: CD001877, 101002/14651858.CD001877.pub2
30. AMERICAN COLLEGE OF RADIOLOGY (ACR). Breast Imaging Reporting and Data System (BIRADS™). 4th ed. Reston VA American College of Radiology 2003
31. Katalinic A, Bartel C, Raspe H, Schreer I. Beyond mammography screening: quality assurance in breast cancer diagnosis. Br J Cancer 2007; 96: 157-161
32. Schreer I, Katalinic A. Is high quality breast imaging and diagnosis possible in a decentralized system? Breast Care 2007; 2: 20-24
33. Madjar H, Ohlinger R, Mundinger A, Watermann D, Frenz J, Bader W, Schulz-Wendlandt R, Degenhardt F. BI-RADS analoge DEGUM Kriterien von Ultraschallbefunden der Brust - Konsensus des Arbeitskreises Mammosonographie der DEGUM. Ultraschall in Med 2006; 27: 374-379
34. NCCN National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian. NCCN Clinical Practice Guidelines in Oncology. USA: Clinical Practice Guidelines in Oncology (http://www.nccn.org) 2007
35. Schwartz G, Veronesi U, Clough K, Dixon J, Fentima I, Heywang-Köbrunner S, Hughes K, Mansel A, Mangolese R, Mendelson E, Olivotte J, Palazzo J, Solin L. Consensus Conference on Breast Conservation. Milan, Italy, April 28 - May 1, 2005. Cancer 2006; 107: 242-250
36. NICE. Breast Cancer: Diagnosis and Treatment. UK: NICE (http://www.nice.org.uk) 2006
37. Crystal P, Koretz M, Shcharynsky S, Makarov V, Strano S. Accuracy of sonographically guided 14-gauge core-needle biopsy: Result of 715 consecutive breast biopsies with at least two-year follow-up of benign lesions. J Clin Ultrasound 2004; 33: 47-51
38. Fishman J, Milikowski C, Ramsinghani R, Velasquez M, Aviram G. US-guided core-needle biopsy of the breast: How many specimens are necessary? Radiology 2003; 226: 779-782
39. NICE. Image-guided vacuum-assisted excision biopsy of benign breast lesions. UK: NICE (http://www.nice.org.uk/IPG156) 2006
40. O'Higgins N, Linos DA, Blichert-Toft M, Cataliotti L, de Wol C, Rochard F, Rutgers E, Roberts P, Mattheim W, da Silva MA, Holmberg L, Schulz KD, Smola MG, Mansel RE. European Guidelines for Quality Assurance in the Surgical Management of Mammographically Detected Lesions. In: Perry N, Broeders M, de Wolf C, Toernberg S, Holland R, von Karsa L (Hrsg). European Guidelines for Quality Assurance in Breast Cancer Sreening and Diagnosis. Luxembourg : Office for official publication of the European Communities, 2006: 315-320
41. Carlson R, Anderson B, Burstein H. NCCN Breast Cancer Clinical practice guidelines in Oncology. USA: National Comprehensive Cancer Network (http://www.nccn.org) 2005
42. Amendoeira I, Apostolikas N, Bellocq J, Bianchi S, Boecker W, Borisch B, Bussolati G, Connolly C, Cserni G, Decker K, Dervan P, Drijkoningen M, Ellis IO, Elston C, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquermier J, Lacerda M, Martinez-Penuela J, De Miquel C, Nordgren H, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafari B, Tanous A, Thorstenson S, Zozoya E, Wells C. Quality assurance guidelines for pathology: open biopsy and resection specismens. In: Wells C (Hrsg). European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. Luxembourg: Office for Official Publications of the European Communities, 2006: 257-311
43. NHSBP. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening (vol NHSBP Publication No. 50). Sheffield NHS Cancer Screening Programmes 2001
44. Amendoeira I, Apostolikas N, Bellocq J, Bianchi S, Boecker W, Borisch B, Bussolati G, Connolly C, Cserni G, Decker K, Dervan P, Drijkoningen M, Ellis IO, Elston C, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquermier J, Lacerda M, Martinez-Penuela J, De Miquel C, Nordgren H, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafari B, Tanous A, Thorstenson S, Zozoya E, Wells C. Quality assurance guidelines for pathology: Cytological and histological non-operative procedures. In: Wells C (Hrsg). European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. Luxembourg : Office for Official Publications of the European Communities, 2006: 221-256
45. WHO. Pathology and genetics of tumours of the breast and female genital organs. In: Tavassoli F, Devilee P (Hrsg). WHO. World Health Organization Classification of Tumours. Lyon : IACR Press, 2003: 9-112
46. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, Lewinsky B, Gamagami P, Slamon DJ. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345: 1154-1157
47. ICSI. Diagnosis of breast disease - guideline ICSI, update 2005. ICSI (http://www.icsi.org) 2005
48. The Association of Breast Surgery at BASO, RCoSoE. Guidelines for the management of symptomatic breast disease. Eur J Surg Oncol 2005; 31: S1-S21
49. Sobin L, Wittekind C. UICC.TNM Classification of malignant tumours. 6th ed. New York A. John Wiley & Sons Inc. Publication 2002
50. Wolff A, Hammond M, Schwartz J, Hagerty K, Allred D, Cote R, Dowsett M, Fitzgibbons P, Hanna W, Langer A, McShane L, Paik S, Pegram M, Perez E, Press M, Rhodes A, Sturgeon C, Taube S, Tubbs R, Vance G, vanD V, Wheeler T, Hayes D. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; 25: 145-145
51. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410
52. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999; 17: 1474-1481
53. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987; 8: 138-140
54. National Quality Management Committee of Breast Screen. Australia: Breastscreen Australia - National Accreditation Standards 2004 (http://www.breastscreen.info.au) 2004
55. NHMRC. Psychosocial clinical practice guideline. Australia: NHMRC (http://www.nhmrc.health.gov.au) 1999
56. Philipps B, Sackett D, Badenoch D, Strauss S, Haynes B, Dawes M. Level of Evidence and Grade of Recommendation. Oxford Centre of Evidence Based Medicine, Oxford 2001. (Dt. autorisierte Übersetzung: Schlömer G. FR Gesundheit, Universität Hamburg, www.gesundheit.uni-hamburg.de/upload/ EVIBAG_methodik_GS_1702.doc)
57. Bundesärztekammer. AWMF, Kassenärztliche Vereinigung (Hrsg). Programm für Nationale Versorgungsleitlinien - Methodenreport. 3. Auflage. Berlin: ÄZQ (www.methodik.n-v-l.de); 2007